Despite the implementation of several alternative strategies for management of respiratory failure in neonates, such as extracorporeal membrane oxygenation, high frequency ventilation, and nitric oxide, conventional assisted ventilation remains the mainstay of treatment. This has traditionally been accomplished by time cycled, pressure limited ventilators over the past three decades primarily because of its ease of application and relative safety. However, several recent advances, both in the concept and the application of conventional ventilation, have been introduced for use in neonates. The introduction of newer, state of the art, microprocessor controlled ventilator systems provides clinicians with opportunities to apply a number of advanced ventilatory modalities not previously available for treating newborns.
Some of these techniques will need further scientific evaluation in controlled trials, but this should not preclude their use in clinical settings, as their safety has already been proved by "standard setters" for use in neonates. There is a firm physiological rationale for their use, and individual centres have already acquired substantial experience in the application of these modalities.
In this paper scientific information and technological advances leading to the newer concepts of ventilatory management in neonates will be addressed, and clinical perspectives based on personal experience will be discussed. Each section includes background information, technical details, clinical application and experience, advantages and limitations, and future perspectives. Equipment Recent advances in microprocessor based, respiratory technology have transformed standard mechanical ventilators. These are now highly sophisticated machines which offer the unique ability to provide rapid and precise control of gas delivery and ventilatory support in various different ways, while allowing for the monitoring and alarming ofvirtually every aspect of the procedures involved.
Detailed technical description of these mechanics is complex and beyond the scope of this article, but salient features relating to individual components of ventilator machinery are described. As these features may be unique to specific ventilators, it is imperative that the user familiarises him or herself with the individual ventilator specifications, while selecting the appropriate device. For this reason, it is always helpful to consider the individual ventilator's mechanics in the following sequence: (a) user interface; (b) gas flow patterns; and (c) the various approaches used to monitor and alarm patient-ventilator functions. This format allows the various devices to be compared in a uniform manner.
The user interface is the interaction between the clinician and the ventilator. Unlike the previous machines, which only displayed data relating to ventilator function as set by the clinician, the current generation of microprocessor controlled ventilators can display output data from the patient, thus making the assisted ventilation much more precise. The system that governs the kinetics of gas flow in the ventilator circuit from the point of its entry, through the breathing circuit, and to its exit through the exhalation system, is an important consideration in terms of ventilator performance and patient safety. "criteris" to achieve full synchronisation in inspiratory and expiratory phase should inspire more forcefully, flow accelerates to maintain target pressure. This "adjustable" flow feature of pressure limited breaths may seem advantageous in terms of improved patient ventilator synchrony, but because of this gas delivery format, tidal volume is variable on a breath-to-breath basis.
In contrast, with volume limited modes, the primary gas delivery target is tidal volume, and peak inspiratory pressure may vary from breath to breath.4 This has been a source of concern to clinicians in the past, but it should be realised that peak pressure measurements are a reflection of airway flow (and resistance) and not necessarily the alveolar pressure, which is primarily determined by compliance and alveolar volume.5 Thus, in volume modes of ventilation, peak inspiratory pressure may "wean"5 automatically as the lung compliance improves either spontaneously or in response to surfactant treatment.
Moreover, the presumption that pressure limited ventilation causes less barotrauma than volume ventilation because of the lower peak inspiratory pressure, may be an oversimplification and is not Pressure support ventilation (PSV) can be defined as patient initiated, pressure targeted, and patient controlled ventilation which is generally flow cycled.'6 This is designed to assist the patient's spontaneous breathing with an inspiratory pressure "boost." Although mostly used as a weaning mode, this can be used as a primary modality in patients with acute or chronic ventilatory failure if they have sufficient respiratory drive. In such patients, PSV reduces the imposed work of breathing, created by the resistive forces of endotracheal tubes, the ventilatory circuit, and demand valve systems. In PSV, once the breath is triggered by patient inspiratory effort, a preset system pressure is rapidly achieved and maintained throughout inspiration by adjustment of machine inspiratory flow. The inspiration ends when the inspiratory flow falls below a preset value, usually determined as a percentage of delivered volume or flow. Although PSV closely resembles A/C ventilation, it seems that because of its unique design, PSV is better customised to support and synchronise with patient effort because the patient has the control of both the inspiratory flow rate and inspiratory time. ' despite inherent difficulties in conducting such controlled trials in critically ill neonates, because the optimal pattern of ventilation varies even in a single infant, presumably reflecting the change in disease process. Moreover, although respiratory failure in neonates represents severe lung injury, it is often associated with a systemic process which may be associated with other organ and tissue injuries. Any new respiratory treatment per se is unlikely to have a total impact on mortality or morbidity. It is also important for the clinicians to realise that despite improvements, conventional ventilation will still fail in certain specific situations where alternative treatments such as ECMO, high frequency ventilation, or nitric oxide administration may have potential benefit.
While mechanical ventilation ofthe newborn is more complex than it has been before, it has never been safer.
